A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis). - Valenti, Mario; Ibba, Luciano; Cascio Ingurgio, Ruggero; Malagoli, Piergiorgio; Carugno, Andrea; Campoli, Marco; Carrera, Carlo G.; Gaiani, Francesca M.; Strippoli, Davide; Mola, Federica; Marzano, Angelo V.; Zerbinati, Nicola; et al. (Dermatology & Therapy, 2024)